SANGUEDOLCE R, RAUSAL, CABIBI D, ARAGONA F, BARRESI E, MARTORANA A CALASCIBETTA A (2005). DIFFERENCE IN KI67 AND THYMIDYLATE SYNTHASE, P53 LEVELS AND THE TREATMENT BY CMF DRUG COMBINATION VERSUS TAXANES IN THE LOCALLY ADVANCED CARCINOMA OF THE BREAST. ??????? it.cilea.surplus.oa.citation.tipologie.CitationProceedings.prensentedAt ??????? 10TH SYMPOSIUM OF EUROPEAN SOCIETY FOR THE STUDY OF PURINE AND PYRIMIDINE METABOLISM IN MAN.

DIFFERENCE IN KI67 AND THYMIDYLATE SYNTHASE, P53 LEVELS AND THE TREATMENT BY CMF DRUG COMBINATION VERSUS TAXANES IN THE LOCALLY ADVANCED CARCINOMA OF THE BREAST

SANGUEDOLCE, Rosario;CABIBI, Daniela;BARRESI, Elisabetta;
2005-01-01

10TH SYMPOSIUM OF EUROPEAN SOCIETY FOR THE STUDY OF PURINE AND PYRIMIDINE METABOLISM IN MAN
PRAGA JUNE 8-11 2005
2005
SANGUEDOLCE R, RAUSAL, CABIBI D, ARAGONA F, BARRESI E, MARTORANA A CALASCIBETTA A (2005). DIFFERENCE IN KI67 AND THYMIDYLATE SYNTHASE, P53 LEVELS AND THE TREATMENT BY CMF DRUG COMBINATION VERSUS TAXANES IN THE LOCALLY ADVANCED CARCINOMA OF THE BREAST. ??????? it.cilea.surplus.oa.citation.tipologie.CitationProceedings.prensentedAt ??????? 10TH SYMPOSIUM OF EUROPEAN SOCIETY FOR THE STUDY OF PURINE AND PYRIMIDINE METABOLISM IN MAN.
Proceedings (atti dei congressi)
SANGUEDOLCE R; RAUSAL; CABIBI D; ARAGONA F; BARRESI E; MARTORANA A CALASCIBETTA A
File in questo prodotto:
Non ci sono file associati a questo prodotto.

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/10447/31034
Citazioni
  • ???jsp.display-item.citation.pmc??? ND
  • Scopus ND
  • ???jsp.display-item.citation.isi??? ND
social impact